BRANDON LIANG: Open Payments
NPI 1912403932 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$744 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $251 · 2025 $744
Food & beverage: $744
| Company | Payments | Amount |
|---|---|---|
| Stryker Corporation | 2 | $256 |
| Braeburn Inc. | 1 | $126 |
| Neurocrine BioSciences, Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Alkermes, Inc. | 1 | $116 |
Products named: UNIVERSAL NEURO 3, BRIXADI, INGREZZA, UZEDY, LYBALVI.
Industry payments across CA — which companies pay providers there.
